share_log

醫渡科技：翌日披露報表

YIDU TECH: Next Day Disclosure Return

香港交易所 ·  Apr 12 19:33
Summary by Futu AI
醫渡科技有限公司於2024年4月12日提交了翌日披露報表，披露公司股份購回情況。根據報表，醫渡科技於同日購回5,000股普通股，每股價格為3.64港元，總計購回金額為18,200港元。該次股份購回後，公司的已發行股本維持在1,062,040,859股，購回股份佔已發行股份的百分比為0.0005%。公司確認，此次股份購回已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關規定。
醫渡科技有限公司於2024年4月12日提交了翌日披露報表，披露公司股份購回情況。根據報表，醫渡科技於同日購回5,000股普通股，每股價格為3.64港元，總計購回金額為18,200港元。該次股份購回後，公司的已發行股本維持在1,062,040,859股，購回股份佔已發行股份的百分比為0.0005%。公司確認，此次股份購回已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關規定。
MEDICAL TECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 12, 2024 DISCLOSING THE REPURCHASE OF THE COMPANY'S SHARES. According to the report, Medical Technology repurchased 5,000 shares of ordinary shares on the same day at a price of HK$3.64 per share for a total repurchase amount of HK$18,200. After the share repurchase, the issued share capital of the company remained at 1,062,040,859 shares, and the share repurchase accounted for 0.0005% of the issued shares. The Company confirms that this share repurchase has been approved by the Board of Directors and complies with the relevant provisions of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
MEDICAL TECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 12, 2024 DISCLOSING THE REPURCHASE OF THE COMPANY'S SHARES. According to the report, Medical Technology repurchased 5,000 shares of ordinary shares on the same day at a price of HK$3.64 per share for a total repurchase amount of HK$18,200. After the share repurchase, the issued share capital of the company remained at 1,062,040,859 shares, and the share repurchase accounted for 0.0005% of the issued shares. The Company confirms that this share repurchase has been approved by the Board of Directors and complies with the relevant provisions of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.